Global pharma industry weighs Russian operations

Mar 21, 2022
Drugmakers have pulled some nonlifesaving products, hesitating to punish ordinary Russians by withdrawing vital treatments.
Insulin pens being manufactured by Eli Lilly & Co. The pharmaceutical giant said it will refocus its efforts in Russia on cancer and diabetes care.
Frederick Florin/AFP Getty Images